Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 12, 2025
Evaluating the learning curves and surgical outcomes of natural orifice specimen extraction surgery (NOSES) for colorectal cancer: A retrospective analysis from a National RegistryYunxiao Liu, Xu Guan, Qing Xu, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|August 24, 2018
[Feasibility analysis on 3D laparoscopic surgery via transrectal extraction of specimens without abdominal incision in the treatment of slow transit constipation]Bing Lu, Chuangang Fu, Zhuqing Zhou, et al.
Cancer Letters|August 5, 2014
Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathwayZhiqi Yu, Chang Zhang, Hao Wang, et al.
Biochemical and Biophysical Research Communications|March 7, 2022
Up-regulated FNDC1 accelerates stemness and chemoradiation resistance in colorectal cancer cellsLin Chen, Jie Liu, Lingfei Wang, et al.
Journal of Nanobiotechnology|May 11, 2021
Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancerYan Zhang, Lin Chen, Xuanting Ye, et al.
Frontiers in Oncology|August 25, 2022
Survival outcomes analysis according to mismatch repair status in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapyLin Chen, Xudong Yang, Yuanyuan Zhang, et al.
Plos One|January 24, 2014
Prognostic significance and molecular mechanism of ATP-binding cassette subfamily C member 4 in resistance to neoadjuvant radiotherapy of locally advanced rectal carcinomaZhiqi Yu, Chang Zhang, Rui Chai, et al.
Journal of Molecular Cell Biology|March 12, 2015
P53 deficiency-induced Smad1 upregulation suppresses tumorigenesis and causes chemoresistance in colorectal cancersXinsen Ruan, Qiao Zuo, Hao Jia, et al.
BMJ Open|November 18, 2016
Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trialLin Chen, Hong Jiang, Wei Gao, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapyYifang Han, Hui Cai, Liye Ma, et al.
Pageof 5